Bacterial lipopolysaccharide induces a conduction block in the sciatic nerves of rats

Laboratory Animal Science

Volumn 49, Issue 1, 1999, Pages 62-69

  Brown, Rhonda F ^a,c   Jackson, Graham D F ^a   Martin, Thomas ^a   Westbrook, R Fred ^a   Pollard, John D ^b   Westland, Kornelius W ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GADOLINIUM CHLORIDE; MACROPHAGE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; EVOKED SOMATOSENSORY RESPONSE; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MACROPHAGE MIGRATION INHIBITION; MALE; NERVE BLOCK; NEUROLOGICAL COMPLICATION; NEUROPATHOLOGY; NONHUMAN; POLYNEUROPATHY; RAT; SCIATIC NERVE;

ANIMALS; DEXAMETHASONE; ELECTROPHYSIOLOGY; ESCHERICHIA COLI; EVOKED POTENTIALS; GADOLINIUM; GLUCOCORTICOIDS; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, WISTAR; SCIATIC NERVE; SPINAL CORD;

EID: 0033066843     PISSN: 00236764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Brown, R. F., and M. Kiernan. 1995. Bacterial endotoxins induce neurological symptoms in adult male Wistar rats. Soc. Neurosci. Abstr. 2124.
2. Brown, R. F., G. D. F. Jackson, T. Martin, et al. 1997. Bacterial lipopolysaccharides induce peripheral nerve disturbances in rats that mimic human immune-mediated polyneuropathies. Lab. Anim. Sci. 47:354-361.
3. Kurtz, H. J., and J. Quast. 1982. Effects of continuous intravenous infusion of Escherichia coli endotoxin into swine. Am. J. Vet. Res. 43:262-268.
4. Ornoy, A., and G. Altshuler. 1975. Maternal endotoxemia, fetal anomalies, and central nervous system damage: a rat model of a human problem. Am. J. Obstet. Gynecol. 124:196-204.
5. Gilles, F. H., A. Leviton, and C. S. Kerr. 1977. Endotoxin leucoencephalopathy in the telencephalon of the newborn kitten. J. Neurol. Sci. 27:183-191.
6. Gilles, F. H., D. R. Averill, and C. S. Kerr. 1977. Neonatal endotoxin encephalopathy. Ann. Neurol. 2:49-56.
7. Winer, J. B., R. A. C. Hughes, M. J. Anderson, et al. 1988. A prospective study of acute idiopathic neuropathy. II. Antecedent events. J. Neurol. Neurosurg. Psychiatry 51:613-618.
8. Kuroki, S., T. Saida, M. Nukina, et al. 1993. Campylobacter jejuni strains from patients with Guillain Barré syndrome belong mostly to Penner serogroup 19 and contain b-N-acetylglucosamine residues. Ann. Neurol. 33:243-247.
9. Zochodne, D. W., C. F. Bolton, G. A. Wells, et al. 1987. Critical illness polyneuropathy: a complication of sepsis and multiorgan failure. Brain 110:819-842.
10. Witt, N. J., D. W. Zochodne, and C. F. Bolton. 1991. Peripheral nerve function in sepsis and multiple organ failure. Chest 99:176-184.
11. Bolton, C. F. 1993. Neuromuscular complications of sepsis. Intensive Care Med. 19:S58-S63.
12. Yuki, N., T. Taki, F. Inagaki, et al. 1993. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 178:1771-1775.
13. Wirguin, I., G. Rosoklija, W. Trojaborg, et al. 1995. Axonal degeneration accompanied by conduction block induced by toxin mediated immune reactivity to GM1 ganglioside in rat nerves. J. Neurol. Sci. 130:17-21.
14. Rees, J. H., N. A. Gregson, P. L. Griffiths, et al. 1993. Campylobacter jejuni and Guillain Barré syndrome. Q. J. Med. 86:623-634.
15. Waage, A. 1987. Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasone. Clin. Immunol. Immunopathol. 45:348-355.
16. Harrison, B. M., L. A. Hansen, J. D. Pollard, et al. 1984. Demyelination induced by serum from patients with Guillain-Barré syndrome. Ann. Neurol. 15:163-170.
17. Sumner, A. J., K. Saida, T. Saida, et al. 1982. Acute conduction block associated with experimental antiserum-mediated demyelination of peripheral nerve. Ann. Neurol. 11:469-477.
18. Brunquell, P. J., G. W. Taylor, G. L. Holmes, et al. 1990. Ontogenesis of lumbar spinal somatosensory evoked potentials after posterior tibial nerve stimulation in the rat. Elect. Clin. Neurophys. 77:112-118.
19. Wietholter, H., and P-J. Hulser. 1985. Lumbar-spinal somatosensory evoked potentials in the rat after stimulation of the tibial nerve. Exp. Neurol. 89:24-31.
20. Westland, K. W., J. D. Pollard, S. Sander, et al. Activated non-neural specific T cells open the blood brain barrier to circulating antibodies. Brain, in press.
21. Zmijewski, C. M., and J. A. Bellanti. 1985. Antigen-antibody interactions, p. 160-175. In J. A. Bellanti (ed.), Immunology: basic processes, 2nd ed. W. B. Saunders Co., Philadelphia.
22. Hays, W. L. 1972. Statistics for the social sciences. Holt, Rinehart & Winston, New York.
23. Miller, R. G. 1966. Simultaneous statistical inference. McGraw Hill Book Co., New York.
24. Liu, S., Z. Sheu, R. Lin, et al. 1997. The in vivo effect of lipopolysaccharide on neuromuscular transmission in the mouse. Eur. J. Pharmacol. 333:241-247.
25. Bishop, G. H. 1960. The relation of nerve fiber size to modality of sensation, p. 88-98. In W. Montagna (ed.), Advances in biology of skin, vol. 1. Pergamon Press, London.
26. Thalhammer, J. G., M. Vladimirova, B. Bershadsky, et al. 1995. Neurologic evaluation of the rat during sciatic nerve block with lidocaine. Anesthesiology 82:1013-1025.
27. Winer, J. B., R. A. C. Hughes, and C. Osmond. 1988. A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J. Neurol. Neurosurg. Psychiatry 51:605-612.
28. Parry, G. J. 1993. Guillain-Barré syndrome. Thieme Medical Publishers, New York.
29. Garcia, G. A., M. J. Lopez, and D. R. Aparicio. 1991. Peripheral polyneuropathy complicating conditions of sepsis and multi-organ failure. Electromyogr. Clin. Neurophysiol. 31:181-186.
30. Bolton, C. F., J. J. Gilbert, A. F. Hahn, et al. 1984. Polyneuropathy in critically ill patients. J. Neurol. Neurosurg. Psychiatry 47:1223-1231.
31. Bolton, C. F., D. A. Laverty, J. D. Brown, et al. 1986. Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry 49:563-573.
32. Ghezzi, P., and J. D. Sipe. 1988. Dexamethasone modulation of LPS, IL-1, and TNF stimulated serum amyloid A synthesis in mice. Lymphokine Res. 7:157-166.
33. Lin, G., A. E. Pearson, R. W. Scamurra, et al. 1994. Regulation of interleukin-8 expression in porcine alveolar macrophages by bacterial lipopolysaccharide. J. Biol. Chem. 269:77-85.
34. Wahl, S. M., and L. M. Wahl. 1985. Regulation of macrophage collagenase, prostaglandin, and fibroblast-activating factor production by anti-inflammatory agents: different regulatory mechanisms for tissue injury and repair. Cell. Immunol. 92:302-312.
35. 2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc. Natl. Acad. Sci. USA 77:2533-2536.
36. Radomski, M. W., R. M. J. Palmer, and S. Moncada. 1990. Glucocorticoids inhibit the expression of an inducible, but not the constitutive nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. USA 87:10043-10047.
37. Schultz, R. M., S. K. Nanda, and M. G. Altom. 1985. Effects of various inhibitors of arachidonic acid oxygenation on macrophage superoxide release and tumoricidal activity. J. Immunol. 135:2040-2044.
38. Decker, K. 1990. Biologically active products of stimulated liver macrophages (kupffer cells). Eur. J. Biochem. 192:245-261.
39. Nathan, C. F. 1992. Secretory products of macrophages. J. Clin. Invest. 79:319-326.
40. Hardonk, M. J., F. W. J. Dijkhuis, C. E. Hulstaert, et al. 1992. Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J. Leukoc. Biol. 52:296-302.
41. Iimuro, Y., M. Yamamoto, H. Kohno, et al. 1994. Blockade of liver macrophages by gadolinium chloride reduces lethality in endotoxaemic rats: analysis of mechanisms of lethality in endotoxaemia. J. Leukoc. Biol. 55:723-728.
42. Roland, C. R., M. J. Mangino, and M. W. Flye. 1993. Lanthanide "blockade" of antigen-presenting cells suppresses lymphocyte proliferation by inducing nitric oxide synthesis. J. Surg. Res. 54:401-410.
43. Paull, S. A., L. Carter, and G. D. F. Jackson. 1988. Immune responses in liver and bile to Escherichia coli O111:B4 lipopolysaccharide, p. 173-184. In J. Levin, J. W. ten Cate, H. R. Buller, et al. (ed.), Bacterial endotoxins: pathophysiological effects, clinical significance, and pharmacological control. Alan R. Liss, Inc., New York.
44. Greisman, S. E., and R. B. Hornick. 1975. The nature of endotoxin tolerance. Trans. Am. Clin. Climatol. Assoc. 86:43-50.
45. Pollack, M. 1992. Specificity and function of lipopolysaccharide antibodies, p. 347-374. In D. C. Morrison and J. L. Ryan (ed.), Bacterial endotoxic lipopolysaccharides. CRC Press, Inc., Boca Raton, Fla.
46. Rioux-Darrieulat, F. M. Parant, and L. Chedid. 1978. Prevention of endotoxin-induced abortion by treatment of mice with antisera. J. Infect. Dis. 137:7-13.
47. Burkel, W. E. 1967. The histological fine structure of the perineurium. Anat. Rec. 158:177-190.
48. Olsson, Y. 1968. Typographical differences in the vascular permeability of the peripheral nervous system. Acta Neuropathol. 10:23-33.
49. Jacobs, J. M., R. M. MacFarlane, and J. B. Cavanaugh. 1976. Vascular leakage in the dorsal root ganglia of the rat, studied with horseradish peroxidase. J. Neurol. Sci. 29:95-107.
50. Seitz, R. J., K. Heininger, G. Schwendemann, et al. 1985. The mouse blood-brain barrier and blood-nerve barrier for IgG: a tracer study by use of the avidin-biotic system. Acta. Neuropathol. 68:15-21.
51. Pourmand, R. 1985. Acquired respiratory failure in critically ill patients. Indiana Med. 88:68-70.
52. Yuki, N., Y. Ichihashi, and T. Taki. 1995. Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome. J. Neuroimmunol. 60:161-164.